Jacalyn Bishop
Pediatric Endocrinology · Novi, MINPI 1063579415
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,700 of the $9,254 with a category attached, or 61.6%. 31 manufacturers reported payments, led by AbbVie at 48.7% of the total. Reporting peaked in 2020 at $3,515 and has fallen 78.1% since, to $769 in 2025. Among pediatric endocrinology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $46.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Tandem Diabetes Care, Inc.$2K
- Novo Nordisk$376
- Medtronic$242
- Tolmar, Inc.$223
- Pfizer$194
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$5,70062%
- Food & beverage$3,54738%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $4,508 |
| Tandem Diabetes Care, Inc. | 12 | $2,179 |
| Novo Nordisk | 22 | $376 |
| Medtronic(2 entities) | 5 | $242 |
| Tolmar, Inc. | 11 | $223 |
| Pfizer | 10 | $194 |
| AstraZeneca | 9 | $155 |
| Boston Scientific | 8 | $138 |
| Eton Pharmaceuticals, Inc. | 2 | $134 |
| Dexcom, Inc. | 5 | $101 |
| Azurity Pharmaceuticals, Inc. | 5 | $96 |
| Rhythm Pharmaceuticals, Inc. | 6 | $95 |
| Ascendis Pharma Endocrinology Inc | 4 | $76 |
| Neurocrine Biosciences, Inc. | 4 | $71 |
| Abbott | 4 | $68 |
| Lilly USA, LLC | 4 | $63 |
| Ferring Pharmaceuticals Inc. | 3 | $53 |
| Sanofi-aventis U.S. LLC | 2 | $52 |
| Ultragenyx Pharmaceutical Inc. | 3 | $51 |
| BETA Bionics, Inc. | 2 | $49 |
| Tolmar Pharmaceuticals, Inc. | 3 | $46 |
| Sandoz | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 3 | $38 |
| Insulet Corporation | 2 | $36 |
| Biomarin Pharmaceutical Inc. | 2 | $33 |
| Lifescan, Inc. | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Mannkind Corporation | 2 | $26 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Zealand Pharma US, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$3,600
- t:slim X2 insulin pump$1,550
- t-slim insulin pump$550
- Minimed 670G System$153
- Alkindi$111
- KHINDIVI$111
- INCRELEX$111
How this compares
$9,254 in reported general payments places this provider in the 90th percentile of 27 pediatric endocrinology providers in Michigan.
Other pediatric endocrinology in Novi
- Michael WoodYpsilanti$59K
- Joyce LeeAnn Arbor$9K
- Daniel ShumerAnn Arbor$8K
- Julie SurhighRoyal Oak$5K
- Kathleen MoltzDetroit$4K
- Daniel ElsholzSaginaw$3K
- Ayman AkkadDearborn$2K
- Kanakadurga SingerAnn Arbor$2K
- Colleen Buggs-SaxtonDetroit$2K
- Christel KeefeGrand Rapids$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.